Genotypic frequencies of CST3 were not statistically significant in ALS patients compared to controls [65], suggesting no expressional difference in cystatin C. The roles of S100-A9, S100B, and CST3 are still unclear in ALS, thus they should be studied further. This evidence concerns the gene S100B and amyotrophic lateral sclerosis.